Hosted on MSN1mon
Oruka Therapeutics inks exclusive license deal with ParagonParagon has agreed not to generate any new anti ... The company has initiated a Phase 1 study for its leading drug candidate, ORKA-001, and has plans to release interim data from this study ...
Erris Homes has secured a £5.4m funding package from Paragon Bank to support the next phase of a development in West Yorkshire. Phase II of Calder Mews in Halifax comprises 14 four-bedroom detached ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results